3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
24
Prostatic Neoplasms
16
Sarcoma
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
5
Uterine Cervical Neoplasms
4
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Pancreatic Neoplasms
2
Neurofibrosarcoma
2
Neoplasms
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Advanced Refractory Solid Tumors
2
Uterine Neoplasms
1
Urothelial Cancer
1
Urogenital Neoplasms
1
Interventions
Proton Therapy
2
tazemetostat
1
selinexor
1
pazopanib
1
Zoledronic Acid
1
Radiation Dose Hypofractionation
1
Protons
1
Nivolumab
1
Neurofibromin 1
1
Ipilimumab
1
Ifosfamide
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Nerve Sheath Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled